Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexander Melamed, M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. OC210024 (MELMAED, ALEXANDER) Sep 22, 2022 - Sep 21, 2026
    DOD/OCRP
    Minimally invasive surgery for ovarian cancer: a pilot randomized trial
    Role Description: The goal of this study learn which patients are likely to be good candidates for minimally invasive cytoreductive surgery after neoadjuvant chemotherapy for ovarian cancer, and whether a definitive clinical trial to establish the efficacy of this intervention is feasible.
  2. KL2TR001874 (SHIMBO, DAICHI) Jul 1, 2016 - May 31, 2021
    NIH
    Institutional Career Development Core
    Role Description: The goals of this project are to develop a model that can identify ovarian cancer patients who received NACT that are likely to be good candidates for minimally invasive cytoreductive surgery and to evaluate whether it is feasible to conduct a phase III randomized trial comparing minimally invasive versus open cytoreductive surgery after NACT for selected advanced ovarian cancer patients.
    Role: KL2 Scholar

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jorgensen K, Nitecki R, Nichols HB, Fu S, Wu CF, Melamed A, Brady P, Chavez Mac Gregor M, Clapp MA, Giordano S, Rauh-Hain JA. Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer. Obstet Gynecol. 2022 Nov 03. PMID: 36357983.
    Citations:    Fields:    
  2. Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Bregar A, Eisenhauer EL, Molina G, Minami C. Guideline-Discordant Care in Early-Stage Vulvar Cancer. Obstet Gynecol. 2022 Nov 03. PMID: 36357957.
    Citations:    Fields:    
  3. Casey JA, Kioumourtzoglou MA, Ogburn EL, Melamed A, Shaman J, Kandula S, Neophytou A, Darwin KC, Sheffield JS, Gyamfi-Bannerman C. Long-Term Fine Particulate Matter Concentrations and Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2: Differential Relationships by Socioeconomic Status Among Pregnant Individuals in New York City. Am J Epidemiol. 2022 Oct 20; 191(11):1897-1905. PMID: 35916364; PMCID: PMC9384549.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  4. Cogan JC, Raghunathan RR, Beauchemin MP, Accordino MK, Huang Y, Elkin EB, Melamed A, Wright JD, Hershman DL. New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer. J Natl Cancer Inst. 2022 Sep 20. PMID: 36130058.
    Citations:    Fields:    
  5. Freret TS, James KE, Melamed A, Gyamfi-Bannerman C, Kaimal AJ, Clapp MA. Antenatal Steroid Exposure Among Term Newborns. JAMA Pediatr. 2022 Sep 19. PMID: 36121659; PMCID: PMC9486637.
    Citations:    Fields:    
  6. Nitecki R, Melamed A. Extra cycles of neoadjuvant chemotherapy before interval surgery for ovarian cancer: the more the merrier or too much of a good thing? Int J Gynecol Cancer. 2022 Jul 20. PMID: 35858713.
    Citations:    Fields:    
  7. Rauh-Hain JA, Zubizarreta J, Nitecki R, Melamed A, Fu S, Jorgensen K, Brady PC, Baker VL, Chavez-MacGregor M, Giordano SH, Keating NL. Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study. Cancer. 2022 09 01; 128(17):3243-3253. PMID: 35767282; PMCID: PMC9378486.
    Citations:    Fields:    
  8. Offodile AC, Lin YL, Melamed A, Rauh-Hain JA, Kinzer D, Keating NL. Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer. JAMA Surg. 2022 06 01; 157(6):e220135. PMID: 35385085; PMCID: PMC8988019.
    Citations:    Fields:    Translation:Humans
  9. Clapp MA, Melamed A, Freret TS, James KE, Gyamfi-Bannerman C, Kaimal AJ. US Incidence of Late-Preterm Steroid Use and Associated Neonatal Respiratory Morbidity After Publication of the Antenatal Late Preterm Steroids Trial, 2015-2017. JAMA Netw Open. 2022 05 02; 5(5):e2212702. PMID: 35583868; PMCID: PMC9118048.
    Citations:    Fields:    Translation:Humans
  10. Cham S, Li A, Rauh-Hain JA, Tergas AI, Hershman DL, Wright JD, Melamed A. Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City. JAMA Oncol. 2022 01 01; 8(1):159-161. PMID: 34817550; PMCID: PMC8777563.
    Citations:    Fields:    Translation:Humans
  11. Melamed A, Rauh-Hain JA, Gockley AA, Nitecki R, Ramirez PT, Hershman DL, Keating N, Wright JD. Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. JAMA Oncol. 2021 Dec 01; 7(12):1782-1790. PMID: 34591081; PMCID: PMC8485210.
    Citations: 3     Fields:    Translation:Humans
  12. Knisely A, Huang Y, Melamed A, Gockley A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Accordino M, Hershman DL, Wright JD. Disparities in Access to High-Volume Surgeons Within High-Volume Hospitals for Hysterectomy. Obstet Gynecol. 2021 08 01; 138(2):208-217. PMID: 34237769.
    Citations: 2     Fields:    Translation:Humans
  13. Wright JD, Huang Y, Melamed A, Albright BB, Hillyer GC, Previs R, Hershman MSDL. Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer. Gynecol Oncol. 2021 09; 162(3):599-605. PMID: 34158181.
    Citations:    Fields:    Translation:Humans
  14. Cogan JC, Raghunathan RR, Beauchemin MP, Accordino MK, Elkin EB, Melamed A, Wright JD, Hershman DL. New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery. Breast Cancer Res Treat. 2021 Sep; 189(2):445-454. PMID: 34089118.
    Citations:    Fields:    Translation:Humans
  15. Wright JD, Cogan JC, Huang Y, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Gockley A, Accordino M, Melamed A, Hershman DL. Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use. JAMA Netw Open. 2021 06 01; 4(6):e2112478. PMID: 34081136.
    Citations: 1     Fields:    Translation:Humans
  16. Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118. PMID: 33957660; PMCID: PMC8141030.
    Citations:    Fields:    Translation:Humans
  17. Wright JD, Chen L, Hur HC, Melamed A, Hershman DL. Trends in Use of Myomectomy for the Surgical Management of Uterine Leiomyomas in Perimenopausal and Postmenopausal Women. Obstet Gynecol. 2021 05 01; 137(5):843-845. PMID: 33831937.
    Citations:    Fields:    Translation:Humans
  18. Wright JD, Chen L, Tergas AI, Melamed A, St Clair CM, Hou JY, Khoury-Collado F, Gockley A, Accordino M, Hershman DL. Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014. JAMA Netw Open. 2021 04 01; 4(4):e218373. PMID: 33914050.
    Citations: 4     Fields:    Translation:Humans
  19. Nitecki R, Melamed A, Gockley AA, Floyd J, Krause KJ, Coleman RL, Matulonis UA, Giordano SH, Lu KH, Rauh-Hain JA. Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials. Gynecol Oncol. 2021 06; 161(3):653-659. PMID: 33736856; PMCID: PMC8164998.
    Citations: 7     Fields:    Translation:Humans
  20. Knisely A, Gamble CR, St Clair CM, Hou JY, Khoury-Collado F, Gockley AA, Wright JD, Melamed A. The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021 03; 28(3):537-543. PMID: 33202311.
    Citations: 4     Fields:    Translation:Humans
  21. Knisely AT, St Clair CM, Hou JY, Collado FK, Hershman DL, Wright JD, Melamed A. Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016. JAMA Netw Open. 2020 09 01; 3(9):e2017517. PMID: 32975569.
    Citations: 9     Fields:    Translation:Humans
  22. Nitecki R, Melamed A. Time to accept a new old standard of care in cervical cancer. Int J Gynecol Cancer. 2020 09; 30(9):1278-1279. PMID: 32796086.
    Citations: 1     Fields:    Translation:Humans
  23. Emeruwa UN, Ona S, Shaman JL, Turitz A, Wright JD, Gyamfi-Bannerman C, Melamed A. Associations Between Built Environment, Neighborhood Socioeconomic Status, and SARS-CoV-2 Infection Among Pregnant Women in New York City. JAMA. 2020 07 28; 324(4):390-392. PMID: 32556085.
    Citations: 65     Fields:    Translation:HumansCellsPHPublic Health
  24. Nitecki R, Rauh-Hain JA, Melamed A, Scambia G, Pareja R, Coleman RL, Ramirez PT, Fagotti A. Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE). Int J Gynecol Cancer. 2020 09; 30(9):1450-1454. PMID: 32690591.
    Citations: 5     Fields:    Translation:Humans
  25. Sisodia RC, Dewdney SB, Fader AN, Wethington SL, Melamed A, Von Gruenigen VE, Zivanovic O, Carter J, Cohn DE, Huh W, Wenzel L, Doll K, Cella D, Dowdy SC. Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part II. Gynecol Oncol. 2020 07; 158(1):201-207. PMID: 32580887.
    Citations: 1     Fields:    Translation:Humans
  26. Sisodia RC, Dewdney SB, Fader AN, Wethington SL, Melamed A, Von Gruenigen VE, Zivanovic O, Carter J, Cohn DE, Huh W, Wenzel L, Doll K, Cella D, Dowdy SC. Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part I. Gynecol Oncol. 2020 07; 158(1):194-200. PMID: 32580886.
    Citations: 1     Fields:    Translation:Humans
  27. Nitecki R, Ramirez PT, Frumovitz M, Krause KJ, Tergas AI, Wright JD, Rauh-Hain JA, Melamed A. Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2020 07 01; 6(7):1019-1027. PMID: 32525511.
    Citations: 35     Fields:    Translation:Humans
  28. Melamed A, Ramirez PT. Changing treatment landscape for early cervical cancer: outcomes reported with minimally invasive surgery compared with an open approach. Curr Opin Obstet Gynecol. 2020 02; 32(1):22-27. PMID: 31815768.
    Citations: 4     Fields:    Translation:Humans
  29. Sia TY, Chen L, Melamed A, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer. Obstet Gynecol. 2019 12; 134(6):1132-1143. PMID: 31764721.
    Citations: 5     Fields:    Translation:Humans
  30. Melamed A, Rauh-Hain JA. Minimally invasive interval cytoreductive surgery: it's time for a randomized trial. Int J Gynecol Cancer. 2019 11; 29(9):1339-1340. PMID: 31685555.
    Citations: 3     Fields:    Translation:Humans
  31. Melamed A, Rauh-Hain JA, Ramirez PT. Minimally Invasive Radical Hysterectomy for Cervical Cancer: When Adoption of a Novel Treatment Precedes Prospective, Randomized Evidence. J Clin Oncol. 2019 11 20; 37(33):3069-3074. PMID: 31560581.
    Citations: 8     Fields:    Translation:Humans
  32. Lietz AP, Weaver DT, Melamed A, Rauh-Hain JA, Wright JD, Wright AA, Knudsen AB, Pandharipande PV. Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model. PLoS One. 2019; 14(9):e0222828. PMID: 31539415.
    Citations:    Fields:    Translation:Humans
  33. Melamed A, Bercow AS, Bunnell K, Rauh-Hain JA, Wright JD, Rice LW, Del Carmen MG. Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer. JAMA Surg. 2019 07 01; 154(7):669-671. PMID: 31066875; PMCID: PMC6506884.
    Citations: 2     Fields:    Translation:Humans
  34. Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AA. Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer. Am J Obstet Gynecol. 2019 12; 221(6):625.e1-625.e14. PMID: 31207237.
    Citations: 8     Fields:    Translation:Humans
  35. Spriggs DR, Melamed A, Li W, Safdar N. Case 18-2019: A 24-Year-Old Woman with a Pelvic Mass. N Engl J Med. 2019 Jun 13; 380(24):2361-2369. PMID: 31189041.
    Citations:    Fields:    Translation:Humans
  36. Wright JD, Khoury-Collado F, Melamed A. Harnessing Minimally Invasive Surgery to Improve Outcomes in Endometrial Cancer Surgery-The Robots Are Coming. JAMA Surg. 2019 06 01; 154(6):539. PMID: 30810712.
    Citations: 2     Fields:    Translation:Humans
  37. Wright JD, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL. Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer. Obstet Gynecol. 2019 06; 133(6):1109-1119. PMID: 31135724; PMCID: PMC6548333.
    Citations: 1     Fields:    Translation:Humans
  38. Moss HA, Melamed A, Wright JD. Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research. Gynecol Oncol. 2019 03; 152(3):533-539. PMID: 30876500.
    Citations: 2     Fields:    Translation:Humans
  39. Zhao Y, Cao J, Melamed A, Worley M, Gockley A, Jones D, Nia HT, Zhang Y, Stylianopoulos T, Kumar AS, Mpekris F, Datta M, Sun Y, Wu L, Gao X, Yeku O, Del Carmen MG, Spriggs DR, Jain RK, Xu L. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc Natl Acad Sci U S A. 2019 02 05; 116(6):2210-2219. PMID: 30659155; PMCID: PMC6369817.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  40. Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, Seagle BL, Alexander A, Barber EL, Rice LW, Wright JD, Kocherginsky M, Shahabi S, Rauh-Hain JA. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med. 2018 Nov 15; 379(20):1905-1914. PMID: 30379613; PMCID: PMC6464372.
    Citations: 175     Fields:    Translation:Humans
  41. Del Carmen MG, Pareja R, Melamed A, Rodriguez J, Greer A, Clark RM, Rice LW. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment. Gynecol Oncol. 2018 09; 150(3):406-411. PMID: 30017539.
    Citations: 5     Fields:    Translation:Humans
  42. Melamed A, Robinson JN. A study design to identify associations: Study design: observational cohort studies. BJOG. 2018 Dec; 125(13):1776. PMID: 29916202.
    Citations: 1     Fields:    Translation:Humans
  43. Melamed A, Robinson JN. Case-control studies can be useful but have many limitations: Study design: case-control studies. BJOG. 2019 Jan; 126(1):23. PMID: 29916200.
    Citations: 3     Fields:    Translation:Humans
  44. Hicks-Courant K, Melamed A, Worley MJ, Kim YB, Schorge JO, Rauh-Hain JA. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States. Obstet Gynecol. 2018 06; 131(6):1111-1120. PMID: 29742673.
    Citations: 2     Fields:    Translation:Humans
  45. Rauh-Hain JA, Melamed A, Schaps D, Bregar AJ, Spencer R, Schorge JO, Rice LW, Del Carmen MG. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Gynecol Oncol. 2018 04; 149(1):4-11. PMID: 29605048.
    Citations: 11     Fields:    Translation:Humans
  46. Weaver DT, Raphel TJ, Melamed A, Rauh-Hain JA, Schorge JO, Knudsen AB, Pandharipande PV. Modeling treatment outcomes for patients with advanced ovarian cancer: Projected benefits of a test to optimize treatment selection. Gynecol Oncol. 2018 05; 149(2):256-262. PMID: 29486993.
    Citations: 2     Fields:    Translation:Humans
  47. Melamed A, Fink G, Wright AA, Keating NL, Gockley AA, Del Carmen MG, Schorge JO, Rauh-Hain JA. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study. BMJ. 2018 01 03; 360:j5463. PMID: 29298771; PMCID: PMC5751831.
    Citations: 16     Fields:    Translation:Humans
  48. Melamed A, Wright AA. Patient Reported Outcomes: Recent Successes and Future Opportunities. Gynecol Oncol. 2018 01; 148(1):1-2. PMID: 29304953.
    Citations:    Fields:    Translation:Humans
  49. Hinchcliff E, Melamed A, Bregar A, Diver E, Clemmer J, Del Carmen M, Schorge JO, Alejandro Rauh-Hain J. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer. Gynecol Oncol. 2018 01; 148(1):168-173. PMID: 29128105.
    Citations: 3     Fields:    Translation:Humans
  50. Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG, Schorge JO, Rauh-Hain JA. Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol. 2017 11; 147(2):250-256. PMID: 28822556.
    Citations: 10     Fields:    Translation:Humans
  51. Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, Del Carmen MG, Rauh-Hain JA. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer. Obstet Gynecol. 2017 07; 130(1):71-79. PMID: 28594773.
    Citations: 11     Fields:    Translation:Humans
  52. Melamed A, Rauh-Hain JA, Schorge JO. Clinical outcomes research in gynecologic oncology. Gynecol Oncol. 2017 09; 146(3):653-660. PMID: 28651803.
    Citations: 1     Fields:    Translation:Humans
  53. Melamed A, Nitecki R, Boruta DM, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA. Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy. Obstet Gynecol. 2017 05; 129(5):861-869. PMID: 28383367.
    Citations: 13     Fields:    Translation:Humans
  54. Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, Del Carmen MG, Rauh-Hain JA. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer. Obstet Gynecol. 2017 03; 129(3):439-447. PMID: 28178043; PMCID: PMC5328143.
    Citations: 26     Fields:    Translation:Humans
  55. Bregar AJ, Melamed A, Diver E, Clemmer JT, Uppal S, Schorge JO, Rice LW, Del Carmen MG, Rauh-Hain JA. Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Data Base. Ann Surg Oncol. 2017 Jun; 24(6):1677-1687. PMID: 28074326.
    Citations: 9     Fields:    Translation:Humans
  56. Rauh-Hain JA, Melamed A, Wright A, Gockley A, Clemmer JT, Schorge JO, Del Carmen MG, Keating NL. Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database. JAMA Oncol. 2017 Jan 01; 3(1):76-82. PMID: 27892998; PMCID: PMC5548189.
    Citations: 28     Fields:    Translation:Humans
  57. Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecol Oncol. 2016 Nov; 143(2):236-240. PMID: 27612977.
    Citations: 24     Fields:    Translation:Humans
  58. Melamed A, Keating NL, Clemmer JT, Bregar AJ, Wright JD, Boruta DM, Schorge JO, Del Carmen MG, Rauh-Hain JA. Laparoscopic staging for apparent stage I epithelial ovarian cancer. Am J Obstet Gynecol. 2017 Jan; 216(1):50.e1-50.e12. PMID: 27567562; PMCID: PMC5618712.
    Citations: 13     Fields:    Translation:Humans
  59. Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, Berkowitz RS, Horowitz NS. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 10; 143(1):73-76. PMID: 27486130.
    Citations: 3     Fields:    Translation:Humans
  60. Sun SY, Melamed A, Joseph NT, Gockley AA, Goldstein DP, Bernstein MR, Horowitz NS, Berkowitz RS. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. Int J Gynecol Cancer. 2016 Feb; 26(2):367-70. PMID: 26588240.
    Citations: 7     Fields:    Translation:Humans
  61. Gockley AA, Melamed A, Joseph NT, Clapp M, Sun SY, Goldstein DP, Horowitz NS, Berkowitz RS. The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol. 2016 Mar; 140(3):470-3. PMID: 26777992.
    Citations: 5     Fields:    Translation:Humans
  62. Melamed A, Rauh-Hain JA, Clemmer JT, Diver EJ, Hall TR, Clark RM, Uppal S, Goodman A, Boruta DM. Changing Trends in Lymphadenectomy for Endometrioid Adenocarcinoma of the Endometrium. Obstet Gynecol. 2015 Oct; 126(4):815-822. PMID: 26348192.
    Citations: 8     Fields:    Translation:Humans
  63. Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, Maestá I, Braga A, Berkowitz RS. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015 Jul; 138(1):46-9. PMID: 25969351.
    Citations: 7     Fields:    Translation:Humans
  64. Melamed A, Katz Eriksen JL, Hinchcliff EM, Worley MJ, Berkowitz RS, Horowitz NS, Muto MG, Urman RD, Feltmate CM. Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer. Ann Surg Oncol. 2016 Jan; 23(1):178-85. PMID: 25956576.
    Citations: 3     Fields:    Translation:Humans
  65. Kaser DJ, Melamed A, Bormann CL, Myers DE, Missmer SA, Walsh BW, Racowsky C, Carusi DA. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril. 2015 May; 103(5):1176-84.e2. PMID: 25747133.
    Citations: 33     Fields:    Translation:Humans
  66. Rauh-Hain JA, Melamed A, Buskwofie A, Schorge JO. Adnexal mass in the postmenopausal patient. Clin Obstet Gynecol. 2015 Mar; 58(1):53-65. PMID: 25565080.
    Citations: 4     Fields:    Translation:Humans
  67. Clapp MA, Melamed A, Robinson JN, Shah N, Little SE. Obstetrician volume as a potentially modifiable risk factor for cesarean delivery. Obstet Gynecol. 2014 Oct; 124(4):697-703. PMID: 25198280.
    Citations: 7     Fields:    Translation:Humans
  68. Melamed A. Electric uterine morcellation. JAMA. 2014 Jul 02; 312(1):96. PMID: 25058230.
    Citations: 1     Fields:    Translation:Humans
  69. Melamed A, Vittinghoff E, Sriram U, Schwartz AV, Kanaya AM. BMD reference standards among South Asians in the United States. J Clin Densitom. 2010 Oct-Dec; 13(4):379-84. PMID: 20663699; PMCID: PMC2966549.
    Citations: 4     Fields:    Translation:Humans
  70. Melamed A, Sorvillo FJ. The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care. 2009; 13(1):R28. PMID: 19250547.
    Citations: 90     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Melamed's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (234)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.